Skip to main content

Correction: Invesco Ltd: Form 8.3 – StoneX Group Inc; Opening Position disclosure

Amendment – this form replaces the Rule 8.3 Disclosure published at 10:58 on 14/10/2024. Changes have been made to section 1(f) of the form. FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree StoneX Group Inc.  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity...

Continue reading

Rihanna’s “Goodnight Gotham” Acquisition by Music Licensing, Inc. (OTC: SONG) Unlocks Significant Royalty Opportunities Across Global Platforms

Naples, FL, Oct. 14, 2024 (GLOBE NEWSWIRE) — Rihanna’s hit track “Goodnight Gotham” has become a key asset in the expanding portfolio of Music Licensing, Inc. (OTC: SONG), following the company’s acquisition of the sound recording rights to the song. This strategic move complements Music Licensing, Inc.’s prior acquisition of the publishing rights to “Goodnight Gotham,” providing the company with comprehensive control over one of the most celebrated works by the globally renowned artist. With over 250 million records sold and 14 Billboard No. 1 hits, Rihanna’s catalog is a valuable asset in the global music rights market, and this acquisition positions Music Licensing, Inc. as a significant player in this fast-growing sector. The sound recording rights will continue to be administered by Universal...

Continue reading

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) — INVO Bioscience (“INVO”) (NASDAQ: INVO) today announced it has closed its merger with NAYA Biosciences, a company dedicated to increasing patient access to breakthrough treatments in oncology and autoimmune diseases. The combined company expects to change its name to NAYA Biosciences and trade on the NASDAQ under the “NAYA” ticker. The combined company will continue to operate the revenue-generating fertility business as well as expand its focus to the development of first-in-class clinical-stage assets in oncology and autoimmune diseases. The combined company will be led by INVO Chief Executive Officer Steve Shum, INVO Chief Financial Officer...

Continue reading

Silver Towne Mint Acquires Assets of Regency Mint Manufacturing

Strategic Tuck-In Acquisition Expected to Increase A-Mark’s Total Minting Capacity to 100MM Ounces Annually Over the Long Term EL SEGUNDO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (Nasdaq: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its wholly owned subsidiary Silver Towne Mint, operated through AM&ST Associates, LLC, has acquired substantially all of the assets of Regency Mint Manufacturing, LLC (Regency Mint), for $2 million. Regency Mint, a 25-year old family-owned and operated business located in Orem, Utah, is an ISO 9001:2015 certified mint that sells primarily to distributors and retailers of precious metals. With the acquisition, Silver Towne Mint acquired all of Regency Mint’s minting equipment, which is expected to be moved shortly to the...

Continue reading

Data Monetization Market to Witness 10.70% CAGR by 2031 | SkyQuest Technology

Westford USA, Oct. 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Data Monetization Market will attain the value of USD 16.98 Billion by 2031, with a CAGR of 10.70% during the forecast period (2024-2031). The rapidly increasing volume of data across the globe and increasing digital transformation are expected to fuel the growth of the data monetization market. The increasing awareness of the benefits of analytics and the adoption of big data analytics worldwide will also create new opportunities for data mining companies. The widespread adoption by organizations around the world and huge investments in improving personalized customer experience. Furthermore, the use of artificial intelligence and machine learning is also driving the growing importance of data globally, and thus changing the demand for data currencies. Conversely,...

Continue reading

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 11 10 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Invesco Ltd: Form 8.3 – StoneX Group Inc; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree StoneX Group Inc.  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – StoneX Group Inc. – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree StoneX...

Continue reading

Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“the “Resulting Issuer” or the “Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. (“Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the “Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures. Completion of Concurrent Financing As previously announced, on October 8, 2024, Conavi completed a concurrent private placement of subscription receipts (“Subscription Receipts”) for gross proceeds of US$7.7 million (the...

Continue reading

Pender Growth Fund Announces Acquisition of Four Technology Companies from Pluribus Technologies

VANCOUVER, British Columbia, Oct. 11, 2024 (GLOBE NEWSWIRE) — (TSXV: PTF) Pender Growth Fund Inc. (“Pender” or the “Company”) is pleased to announce the completed acquisition of four technology companies from Pluribus Technologies Corp. (“Pluribus”) (TSXV:PLRB). The acquisition is being made by a majority owned subsidiary, to be named Pender Software Holdings Ltd., held approximately 85% by Pender and 15% by Acorn Partners Inc. The total cash consideration for the transaction is C$17.0 million, subject to working capital adjustments, performance and other customary holdbacks. All four companies are currently cash flow positive. The four technology companies acquired are:POWR Inc. (www.powr.io) – Founded in 2014 and headquartered in San Francisco (US), POWR is one of the web’s leading plugin libraries that helps eCommerce businesses...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.